At a glance
ClinicalIndex Comparison RecordN/ACompleted· 9 enrolled
Drug / intervention
Indocyanine green +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Intraoperative Evaluation of Axillary Lymphatics for Breast Cancer Patients Undergoing Axillary Surgery
In Brief
A clinical study evaluating OnLume Imaging System and Indocyanine green for Lymphedema and 2 related conditions. Completed, enrolled 9 participants across 1 site.
Detailed Summary
This study will assess the feasibility of using the OnLume Imaging System for fluorescence-guided surgery along with indocyanine green (ICG) dye in the operating room for the axillary reverse mapping (ARM) procedure in women with breast cancer scheduled to have axillary dissection (AD) or sentinel lymph node (SLN) biopsy.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLymphedema, Surgery, Breast Cancer
CountriesUnited States
Timeline
N/ACompletedFinished
20222023202420252026
First PostedOct 2021
Enrollment StartMay 2022
Primary CompletionApr 2023
TodayJul 2026
First PostedOct 26, 2021
Enrollment StartMay 5, 2022
Primary CompletionApr 27, 2023
TodayJul 2, 2026
Enrollment to primary: 12 monthsPosted 4.7 years ago
Interventions
OnLume Imaging Systemdevice
for fluorescence-guided surgery with ICG dye
Indocyanine greendrug
Indocyanine green is a cyanine dye used in medical diagnostics